Syneron Medical Ltd. Cashflow Statement

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2016 12 months to Dec 31, 2016	FY2015 12 months to Dec 31, 2015	FY2014 12 months to Dec 31, 2014	FY2013 12 months to Dec 31, 2013	FY2012 12 months to Dec 31, 2012
Cash flows from operating activities:
Net income (loss)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Depreciation and amortization
Share-based compensation
Changes in fair value of investment in affiliated company
Impairment of investment in affiliated companies
Impairment of intangible assets and goodwill
Gain from sale of subsidiary
Subsidiary's assets and liabilities, net
Proceeds From Divestiture Of Interest In Subsidiaries And Affiliates
Decrease in accrued interest, amortization of premium and accretion of discount and gain from sale of marketable securities
Change in fair value of contingent consideration, net
Deferred income taxes, net
Decrease (increase) in trade receivables, net
Decrease (increase) in other accounts receivable and prepaid expenses
Increase in inventories
Increase in trade payables
Increase (decrease) in deferred revenues
Increase in warranty accruals
Increase (decrease) in other accounts payable and accrued expenses
Other, net

Net cash provided by (used in) operating activities
Cash flows from investing activities:
Proceeds from investment in short-term deposits, net
Purchase of available-for-sale marketable securities
Proceeds from sale of available-for-sale marketable securities
Redemption of available-for-sale marketable securities
Investments in affiliated company
Purchase of property and equipment
Net cash paid in acquisition of subsidiaries (a)
Purchases of intangible asset
Investment in affiliated company
Sale of a subsidiary
Other, net
Net cash provided by (used in) investing activities

Cash flows from financing activities:
Additional payment to non-controlling shareholders
Repurchase of ordinary shares
Exercise of stock options and RSU's
Repayment of short-term bank credit, net
Net cash provided by (used in) financing activities

Translation adjustments on cash and cash equivalents
Increase (decrease) in cash and cash equivalents
Cash and cash equivalents at the beginning of the year
Cash and cash equivalents at the end of the year
Supplemental disclosure of cash flow information:
Cash paid during the year for income taxes, net
Supplemental disclosure of non-cash financing and investing activities:
Reclassification of inventory to property and equipment
Investment in affiliated company

(a) Net cash paid in acquisition of subsidiary:
Cash
Cash acquired
Current assets
Non-current assets
Consideration: Cash
Total consideration
Identifiable assets acquired and liabilities assumed:
Cash acquired
Short term bank credit
Current assets
Non-current assets
Intangible assets
Goodwill
Deferred tax liabilities
Contingent consideration
Liabilities assumed
Total identifiable assets acquired and liabilities assumed:
Goodwill (bargain purchase price)

Net cash paid in acquisitions

Consideration: Investment in Iluminage Beauty at fair value
Total consideration
Current assets
Non-current assets
Intangible assets, net
Goodwill
Current liabilities
Non- current liabilities
Non-controlling interests

Comments